Effects of the proapoptotic regulator Bcl‑2/adenovirus EIB 19‑kDa‑interacting protein 3 on the chemosensitivity of human colon cancer cell lines

  • Authors:
    • Zi Wang
    • Chunmei Huang
    • Jianshuang Zeng
    • Qian Deng
    • Hui Zeng
    • Zhen Liu
    • Xingchen Peng
    • Feng Bi
    • Qiulin Tang
    • Zhiping Li
  • View Affiliations

  • Published online on: September 21, 2012     https://doi.org/10.3892/ol.2012.933
  • Pages: 1195-1202
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In the clinical setting, drug resistance remains a significant obstacle for successful chemotherapy. Bcl‑2/adenovirus EIB 19‑kDa‑interacting protein 3 (BNIP3) is a proapoptotic member of the Bcl‑2 family. To address its potential as a therapeutic target for chemosensitisation, this study investigated the effect of BNIP3 expression on chemosensitivity and reversal of oxaliplatin (L‑OHP) resistance in human colon cancer cell lines. A plasmid expressing the BNIP3 gene was transfected into human parental colon cancer cell lines (SW620 and colo320) and L‑OHP‑resistant colon cancer cell lines (SW620/L‑OHP and colo320/L‑OHP) using Lipofectamine™ 2000, and the transfection efficiency was determined using fluorescence optics. Western blot analysis identified that SW620/L‑OHP and colo320/L‑OHP cells expressed lower levels of BNIP3 protein compared with the SW620 and colo320 cells. Transfection with the recombinant BNIP3 plasmid revealed an increase in BNIP3 expression in tumour cells. Following transfection with pDsRed‑BNIP3, the chemosensitivity of parental and L‑OHP‑resistant cell lines to L‑OHP was increased (P<0.01), as detected by the Cell Counting Kit‑8 (CCK8) assay. Hoechst 33342 staining and flow cytometry revealed that the effects on L‑OHP‑induced apoptosis were enhanced by the overexpression of BNIP3. Chemosensitisation in human colon cancer cells was observed following treatment with the recombinant BNIP3 plasmid in vitro. The results of this study suggest that BNIP3 is a potential therapeutic target for reversing the resistance of L‑OHP‑resistant colon cancer cells to L‑OHP.
View Figures
View References

Related Articles

Journal Cover

December 2012
Volume 4 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang Z, Huang C, Zeng J, Deng Q, Zeng H, Liu Z, Peng X, Bi F, Tang Q, Li Z, Li Z, et al: Effects of the proapoptotic regulator Bcl‑2/adenovirus EIB 19‑kDa‑interacting protein 3 on the chemosensitivity of human colon cancer cell lines. Oncol Lett 4: 1195-1202, 2012
APA
Wang, Z., Huang, C., Zeng, J., Deng, Q., Zeng, H., Liu, Z. ... Li, Z. (2012). Effects of the proapoptotic regulator Bcl‑2/adenovirus EIB 19‑kDa‑interacting protein 3 on the chemosensitivity of human colon cancer cell lines. Oncology Letters, 4, 1195-1202. https://doi.org/10.3892/ol.2012.933
MLA
Wang, Z., Huang, C., Zeng, J., Deng, Q., Zeng, H., Liu, Z., Peng, X., Bi, F., Tang, Q., Li, Z."Effects of the proapoptotic regulator Bcl‑2/adenovirus EIB 19‑kDa‑interacting protein 3 on the chemosensitivity of human colon cancer cell lines". Oncology Letters 4.6 (2012): 1195-1202.
Chicago
Wang, Z., Huang, C., Zeng, J., Deng, Q., Zeng, H., Liu, Z., Peng, X., Bi, F., Tang, Q., Li, Z."Effects of the proapoptotic regulator Bcl‑2/adenovirus EIB 19‑kDa‑interacting protein 3 on the chemosensitivity of human colon cancer cell lines". Oncology Letters 4, no. 6 (2012): 1195-1202. https://doi.org/10.3892/ol.2012.933